Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$2.04 USD
+0.11 (5.70%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $2.05 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.20 | 0.00% |
Earnings Summary
For their last quarter, Pacific Biosciences of California (PACB) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.24 per share. This reflects a positive earnings surprise of 16.67%. Look out for PACB's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 25.93%.
Earnings History
Price & Consensus
Zacks News for PACB
PacBio Stock Drops After Singapore Collaboration for HiFi Sequencing
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services